MeridianConsensus
Operator profileMDTDublin, IrelandData as of May 2026

Medtronic plc

Medtronic plc is medical device company. Founded in 1949. Led by CEO William A. Hawkins. Approximately 86,000 employees. (Wikidata)

Medtronic plc's strongest tracked position is the Interventional Cardiology Market at an estimated 15.0% share in a market growing at 6.3% CAGR. Average estimated share across all tracked markets is 12.1%, indicating a concentrated leadership position.

Meridian Consensus tracks Medtronic plc in 3 markets across 1 industry (Healthcare). Estimated in-market revenue is $3.6B, the sum of share × market size across appearances — a modeled figure, not reported company revenue.

Filed financials · SEC 10-K · FY2026

EDGAR · CIK 1613103
Revenue (filed)
$36.4B
Net income (filed)
$4.8B
Total assets (filed)
$93.0B

Exchange-filed figures from SEC XBRL companyfacts (Medtronic plc). The modeled in-market estimates below cover only the markets Meridian tracks and will not sum to filed revenue.

Markets tracked
3
Industries
1
Est. in-market revenue
$3.6B
Top market share
15.0%

Share and revenue figures are Meridian model estimates reconciled through the publish-gate validator, not audited financials. Methodology

Market positions

Avg share 12.1% · sorted by est. revenue
MarketCAGRShare
Interventional Cardiology Market6.3%15.0%
Neurovascular Devices Market8.4%20.0%
Thrombus Aspiration Catheter Market8.1%1.2%
Positioning · est. share vs market growth (dot size = market size)
high share · fast marketlow share · slow marketMarket CAGR (010%)Est. share (0–25%)Interventional Cardiology
Est. revenue by market (share × market size)
Interventional Cardiology$2.8B
Neurovascular Devices$840M
Thrombus Aspiration Catheter$24M

Meridian Dossier

Need diligence-grade depth on Medtronic plc?

Commission a source-cited diligence dossier on Medtronic plc: identity, filed financials, IP, litigation, and government exposure. Free preview first, from $299.

Medtronic plc: frequently asked

Meridian Consensus tracks Medtronic plc in 3 markets: Interventional Cardiology Market ($18.5B), Neurovascular Devices Market ($4.2B), Thrombus Aspiration Catheter Market ($2.0B), spanning Healthcare.

Medtronic plc's strongest tracked position is the Interventional Cardiology Market, a $18.5B market growing at 6.3% CAGR, where it holds an estimated 15.0% share as of May 2026.

Across Meridian-tracked markets, Medtronic plc's closest peers are Boston Scientific, Terumo Corporation, Teleflex, Meril Life Sciences, Penumbra Inc., with the largest overlap in the Interventional Cardiology Market. Peer mapping is based on co-appearance in the same tracked markets.

No. Share and revenue figures on this page are model estimates produced by Meridian's research pipeline and committee-reviewed before publication; they are not audited or exchange-filed financials. Market-level sizings are reconciled against external sources during the publish gate.

Adjacent markets in Healthcare

Tracked markets in the same industry where Medtronic plc is not among the named operators. Each carries Porter Five Forces, SWOT, country analysis, and a full competitor table.

Operators that compete with Medtronic plc

Meridian Consensus Digest

Free · Weekly

Not ready to commission a full report? Get our weekly briefing instead: new market sizings, thesis revisions, and reconciliation updates. Signed by the research team. No sales emails.

Subscribed by teams in Corporate Development, PE, and Management Consulting. Unsubscribe in one click.